Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-25-001924

Options or other derivatives

  • CHIEF LEGAL OFFICER AND GC acquired 230,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harsch Mutya · CHIEF LEGAL OFFICER AND GC

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-21 Grant or award : show line 1 in the form Stock Option (right to buy) +230,000 230,000 D
Loading xslF345X05/form4-01232025_040104.xml…